Loading...
Oral Anticoagulant Therapy in Patients Receiving Haemodialysis: Is It Time to Abandon It?
Oral anticoagulant (OAC) therapy in haemodialysis patients causes a great deal of controversy. This is because a number of pro- and anticoagulant factors play an important role in end-stage renal failure due to the nature of the disease itself. In these conditions, the pharmacokinetic and pharmacody...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3863463/ https://ncbi.nlm.nih.gov/pubmed/24379737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/170576 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|